Gerrit Borchard

发表

Tiziana Di Francesco, Gerrit Borchard, 2018 .

Developing and Testing of Drug Carrier Systems for Pulmonary Drug Delivery

Gerrit Borchard, Maytal Bivas-Benita, Hans E. Junginger, 2004, 2004 International Conference on MEMS, NANO and Smart Systems (ICMENS'04).

Non-biological complex drugs (NBCDs) and their follow-on versions: time for an editorial section

Gerrit Borchard, Vinod P. Shah, Jon S. B. de Vlieger, 2015 .

How the Lack of Chitosan Characterization Precludes Implementation of the Safe-by-Design Concept

Gerrit Borchard, Claudia Som, Cíntia Marques, 2020, Frontiers in Bioengineering and Biotechnology.

Regulatory challenges and approaches to characterize nanomedicines and their follow-on similars.

Gerrit Borchard, Stefan Mühlebach, G. Borchard, 2015, Nanomedicine.

Mucoadhesive Polymers in Peroral Peptide Drug Delivery. II. Carbomer and Polycarbophil Are Potent Inhibitors of the Intestinal Proteolytic Enzyme Trypsin

Gerrit Borchard, Hans E. Junginger, H. Junginger, 1995, Pharmaceutical Research.

Equivalence of complex drug products: advances in and challenges for current regulatory frameworks

Gerrit Borchard, Scott McNeil, Beat Flühmann, 2017, Annals of the New York Academy of Sciences.

Progress in chitosan-based vaccine delivery systems

Gerrit Borchard, Hans E. Junginger, H. Junginger, 2010 .

Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis.

Gerrit Borchard, Annemieke Geluk, Tom H M Ottenhoff, 2004, Vaccine.

The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro

Gerrit Borchard, Hans E. Junginger, H. Junginger, 1996 .

In vitro evaluation of intestinal absorption of desmopressin using drug-delivery systems based on superporous hydrogels.

Gerrit Borchard, Narong Sarisuta, H. Junginger, 2004, International journal of pharmaceutics.

Complex molecules – current developments

Gerrit Borchard, G. Borchard, 2014 .

Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles.

Gerrit Borchard, Joana Tavares, Anabela Cordeiro-da-Silva, 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination.

Gerrit Borchard, Anabela Cordeiro-da-Silva, H. Junginger, 2006, Journal of controlled release : official journal of the Controlled Release Society.

Gender-specific differences between the concentrations of nonvolatile (R)/(S)-3-methyl-3-sulfanylhexan-1-Ol and (R)/(S)-3-hydroxy-3-methyl-hexanoic acid odor precursors in axillary secretions.

Gerrit Borchard, Christine Vuilleumier, Sophie Raviot-Derrien, 2008, Chemical senses.

Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures

Gerrit Borchard, Hans E. Junginger, H. Junginger, 2002, AAPS PharmSci.

Bridging communities in the field of nanomedicine

Thierry Bastogne, Valérie Zuang, Patrick Boisseau, 2019, Regulatory toxicology and pharmacology : RTP.

Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.

Gerrit Borchard, Anabela Cordeiro-da-Silva, H. Junginger, 2008, International immunopharmacology.

Peroral Absorption of Octreotide in Pigs Formulated in Delivery Systems on the Basis of Superporous Hydrogel Polymers

Gerrit Borchard, Hans E. Junginger, M. Rafiee-Tehrani, 2002, Pharmaceutical Research.